display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
metastatic/advanced - colorectal cancer (mCRC)
endometrial cancer
pembrolizumab based treatment
pembrolizumab plus lenvatinib KEYNOTE-775 KEYNOTE-775

Study type: